Insulet (Nasdaq:PODD) announced today that SVP and Chief Technology Officer Mark Field is departing the company. Field left the automated insulin delivery technology developer to pursue other opportunities, effective March 14, according to an SEC filing. As the company searches for Field’s successor, it tapped Amit Guliani to hold the post of interim CTO, effective […]
Diabetes
Insulet expands Omnipod 5 to more countries, prices $450M offering
Insulet (Nasdaq:PODD) announced today that it made its Omnipod 5 automated insulin delivery system available in several new geographies. The company made Omnipod 5 available in Australia and has planned launches for Belgium, Canada and Switzerland in the near term. This follows the launch of Omnipod 5 in five new European countries at the start […]
Sequel Med Tech makes first CGM integration with Abbott for automated insulin pump
Sequel Med Tech announced today that it integrated its twiist automated insulin delivery (AID) with the Abbott FreeStyle Libre 3 Plus sensor. This marks the first continuous glucose monitor (CGM) integration for twiist. Manchester, New Hampshire-based Sequel expects to launch the combination in the second quarter of 2025. Sequel won FDA clearance for the twiist […]
Vivani reports first human GLP-1 implant for weight loss in adults
Vivani Medical (Nasdaq:VANI) announced today that it successfully administered the first GLP-1 implant in its LIBERATE-1 clinical trial. This news comes just one day after Vivani announced plans to spin off its neurostimulation business to focus on its GLP-1 implants. The company also announced full enrollment in LIBERATE-1, achieved in just four weeks after the […]
Trinity Biotech to undergo strategic realignment, focus on CGM development
Trinity Biotech (Nasdaq:TRIB) today announced the next stage of its transformation plan as it looks to bring a continuous glucose monitor (CGM) to market. Dublin, Ireland-based Trinity Biotech appointed Barclays as its exclusive financial advisor to support an ongoing strategic realignment. The company aims to increase its focus on its “disruptive” CGM technology as part […]
Dexcom receives FDA warning letter
Dexcom (Nadsaq:DXCM) announced today that it received a warning letter from the FDA following inspections of two company facilities. The letter followed inspections of the company’s plants in San Diego and Mesa, Arizona. San Diego is where Dexcom’s headquarters is located, while the company last year decided to move manufacturing out of San Diego to […]
Real-world data backs Insulet Omnipod 5 in children
A recently published study highlighted the strong performance of the Insulet (Nasdaq:PODD) Omnipod 5 in children and young people. Omnipod 5, Insulet’s latest-generation automated insulin delivery (AID) system, is a small, discreet, tubeless, wearable patch pump. It features SmartAdjust technology that uses CGM readings to predict where glucose will be 60 minutes into the future. […]
Senseonics expects to double global patient base in 2025, progresses with pump integration
Senseonics (NYSE:SENS) shares ticked up after hours today on fourth-quarter results that came in ahead of the consensus forecast. Shares of SENS went up nearly 7% to 93¢ apiece in post-market trading today. The Germantown, Maryland-based long-term implantable continuous glucose monitor maker reported losses of $15.5 million for the quarter. That equals losses 2¢ per […]
New funding supports Vitasense non-invasive glucose monitoring tech
Startup Vitasense today said it secured significant funding to advance its non-invasive wearable glucose monitoring technology. Junior high innovator Max Kopp from Germantown Academy in Pennsylvania leads the diabetes management startup. Crown Wealth, with strategic collaboration from KB Global Holding and other top universities, provided the undisclosed funding. The company said its funding marks a […]
Pump shipments increase by 25% in Q4 sales beat for Tandem
Tandem Diabetes Care (Nasdaq:TNDM) shares took a hit after hours today on fourth-quarter results that topped the consensus sales forecast. Shares of TNDM fell 11% to $29.88 apiece in post-market trading today. The San Diego-based automated insulin delivery technology company reported profits of $755,000. That equals 1¢ per share on sales of $282.65 million for […]
